Canton Strategic Sells Biotech Subsidiary Gravitas, Shifts Focus to Financial Digitalization

Odaily Planet Daily News: Canton Strategic Holdings, a Nasdaq-listed company, announced the completion of the sale of its biotech R&D subsidiary, Gravitas Life Sciences. The buyer for this transaction is Gravitas Collective Corp. The deal received unanimous approval from the company's board of directors and was officially closed on July 17, 2026.

This asset divestiture is a key strategic transformation move for the company. Going forward, the company will focus on the Canton Network ecosystem, transforming into a digitalization service provider for financial markets. It will prioritize the implementation of asset tokenization and financial digitalization, while continuously improving its compliant financial infrastructure business. (PRNewswire)